{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:49:16Z","timestamp":1790196556166,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.jcmgh.2019.08.006","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:56:50Z","timestamp":1566907010000},"page":"47-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice"],"prefix":"10.1016","volume":"9","author":[{"given":"Pauline T.","family":"Ikpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Doktorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly F.","family":"Meijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha D.A.","family":"Nieuwenhuijze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henkjan J.","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo R.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel J.C.","family":"Bijvelds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2019.08.006_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1665-2681(19)31949-0","article-title":"Biliary secretion and excretion in health and disease: current concepts","volume":"6","author":"Hofmann","year":"2007","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib2","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib3","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1194\/jlr.M700351-JLR200","article-title":"FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption","volume":"48","author":"Jung","year":"2007","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/gutjnl-2012-302945","article-title":"Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice","volume":"62","author":"Uriarte","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib7","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/hep.25905","article-title":"Promotion of liver regeneration\/repair by farnesoid X receptor in both liver\u00a0and intestine in mice","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.28257","article-title":"Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib10","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.3390\/ijms150813529","article-title":"Cystic fibrosis related liver disease: another black box in hepatology","volume":"15","author":"Staufer","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1053\/j.gastro.2011.06.052","article-title":"Loss of CFTR affects biliary\u00a0epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice","volume":"141","author":"Fiorotto","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(96)80326-6","article-title":"Bile acid kinetics and biliary lipid composition in cystic fibrosis","volume":"25","author":"Strandvik","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcf.2018.09.001","article-title":"Ivacaftor restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation","volume":"18","author":"Van de Peppel","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib15","first-page":"G646","article-title":"Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events","volume":"288","author":"Bijvelds","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib16","first-page":"G1411","article-title":"Pathophysiological basis of liver disease in cystic fibrosis employing a DF508 mouse model","volume":"294","author":"Freudenberg","year":"2008","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib17","first-page":"G1035","article-title":"Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice","volume":"302","author":"Bodewes","year":"2012","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib18","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1053\/j.gastro.2012.02.033","article-title":"Defects in gallbladder emptying and bile acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies","volume":"142","author":"Debray","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117599","article-title":"Cholic acid induces a Cftr dependent biliary secretion and liver growth response in mice","volume":"10","author":"Bodewes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jhep.2015.04.030","article-title":"Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4","volume":"63","author":"Out","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.celrep.2014.02.032","article-title":"Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice","volume":"7","author":"Degirolamo","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib23","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1074\/jbc.M212633200","article-title":"Repression of farnesoid X receptor during the acute phase response","volume":"278","author":"Kim","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib24","doi-asserted-by":"crossref","first-page":"16390","DOI":"10.1074\/jbc.M000953200","article-title":"The acute phase response is associated with retinoid X receptor repression in rodent liver","volume":"275","author":"Beigneux","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib25","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/ncomms5573","article-title":"PPARalpha-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis","volume":"5","author":"Zhou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib26","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1097\/MIB.0000000000000879","article-title":"Alterations in enterohepatic Fgf15 signaling and changes in bile acid composition depend on localization of murine intestinal inflammation","volume":"22","author":"Rau","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib27","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1128\/IAI.72.10.6040-6049.2004","article-title":"Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine","volume":"72","author":"Norkina","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/gmic.22430","article-title":"Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota","volume":"4","author":"Lynch","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib29","first-page":"G1032","article-title":"Inflammation of the cystic fibrosis mouse small intestine","volume":"286","author":"Norkina","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085254","article-title":"Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture","volume":"9","author":"Sommer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ni.3587","article-title":"Epithelial glycosylation in gut homeostasis and inflammation","volume":"17","author":"Goto","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj20020371","article-title":"Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase","volume":"367","author":"Thomsson","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079883","article-title":"Mice overexpressing beta-1,4-galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis","volume":"8","author":"Vanhooren","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature13823","article-title":"Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness","volume":"514","author":"Pickard","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbadis.2011.04.005","article-title":"Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine","volume":"1812","author":"Gadaleta","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1121435","article-title":"Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration","volume":"312","author":"Huang","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib38","article-title":"Transcriptome analysis of the distal small intestine of Cftr null mice","author":"Ikpa","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib39","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.20120562","article-title":"Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype","volume":"209","author":"Gustafsson","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib40","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.07.014","article-title":"Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the cystic fibrosis intestine","volume":"16","author":"Dorsey","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02766-16","article-title":"Ursodeoxycholic acid and its taurine- or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice","volume":"83","author":"Van den Bossche","year":"2017","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib42","doi-asserted-by":"crossref","first-page":"16241","DOI":"10.1038\/s41598-018-34263-4","article-title":"Human defensin-5 blocks ethanol and colitis-induced dysbiosis, tight junction disruption and inflammation in mouse intestine","volume":"8","author":"Shukla","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2018.12.018","article-title":"Defective CFTR promotes intestinal proliferation via inhibition of the hedgehog pathway during cystic fibrosis","volume":"446","author":"Liu","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.aam9949","article-title":"Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion","volume":"357","author":"Byndloss","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2101","article-title":"Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice","volume":"16","author":"Harmon","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcp.20020","article-title":"Decreased expression of peroxisome proliferator activated receptor gamma in cftr-\/- mice","volume":"200","author":"Ollero","year":"2004","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib48","first-page":"G157","article-title":"Expression and transport properties of the human ileal and renal sodium- dependent bile acid transporter","volume":"274","author":"Craddock","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib49","first-page":"G996","article-title":"beta-Klotho and FGF-15\/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes","volume":"295","author":"Sinha","year":"2008","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/pr.2011.4","article-title":"Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis","volume":"71","author":"Wouthuyzen-Bakker","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib51","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jcf.2014.12.010","article-title":"Altered intestinal bile salt biotransformation in a cystic fibrosis (Cftr-\/-) mouse model with hepato-biliary pathology","volume":"14","author":"Bodewes","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib52","first-page":"G577","article-title":"Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine","volume":"293","author":"De Lisle","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/PL00009970","article-title":"Overgrowth and translocation of Escherichia coli from intestine during prolonged enteral feeding in rats","volume":"35","author":"Kayama","year":"2000","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib54","first-page":"G404","article-title":"Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol","volume":"316","author":"Bertolini","year":"2019","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib55","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.103.1.52","article-title":"Clinical and genetic risk factors for cystic fibrosis-related liver disease","volume":"103","author":"Wilschanski","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib57","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib58","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1113\/jphysiol.2012.232124","article-title":"Rescue of epithelial HCO3- secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del","volume":"590","author":"Xiao","year":"2012","journal-title":"J\u00a0Physiol (Lond)"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00418-016-1453-4","article-title":"Guanylin and uroguanylin are produced by mouse intestinal epithelial cells of columnar and secretory lineage","volume":"146","author":"Ikpa","year":"2016","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib60","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1128\/AEM.01906-15","article-title":"Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in mouse feces","volume":"81","author":"Yang","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/9780470942390.mo130179","article-title":"Establishment of gastrointestinal epithelial organoids","volume":"3","author":"Mahe","year":"2013","journal-title":"Curr Protoc Mouse Biol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib62","first-page":"G870","article-title":"Activation of CFTR by ASBT-mediated bile salt absorption","volume":"289","author":"Bijvelds","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib63","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1042\/bj2360771","article-title":"Efficient entrapment of large and small compounds during vesiculation of intestinal microvilli","volume":"236","author":"Van Dommelen","year":"1986","journal-title":"Biochem J"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2091-2-11","article-title":"Differential modulation of cellular death and survival pathways by conjugated bile acids","volume":"2","author":"Torchia","year":"2001","journal-title":"BMC Biochem"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9673(00)88374-0","article-title":"Gas-liquid chromatography of fecal neutral steriods","volume":"135","author":"Gerhardt","year":"1977","journal-title":"J\u00a0Chromatogr"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.jcmgh.2019.08.006_bib67","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X19301122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X19301122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:22:50Z","timestamp":1762453370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X19301122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["S2352345X19301122"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2019.08.006","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2019.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}